Completed PHASE3 INTERVENTIONAL 2-arm NCT00289224

Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata

A Randomized Controlled Trial of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India

Sponsor: International Vaccine Institute

Conditions Cholera Diarrhea Vibrio Infections

Interventions Placebo bivalent killed whole cell oral cholera vaccine

Updated 5 times since 2017 Last updated: Jul 30, 2014 Started: Jul 31, 2006 Primary completion: Dec 31, 2011 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cholera and Diarrhea and is currently completed. International Vaccine Institute leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Vaccine Institute
National Institute of Cholera and Enteric Diseases, India
Shantha Biotechnics Limited

Data source: International Vaccine Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kolkata, India